Understanding what autoimmune diseases are, what triggers them and how they’re treated can be a powerful first step toward ...
Pharmaceutical Technology on MSN
Sanofi and Earendil Labs forge $2.56bn autoimmune deal
GlobalData analyst Vasilis Roumpelakis notes that bispecifics could hold strong potential in the future, but manufacturing ...
A phase 3 study of Zenas BioPharma's autoimmune disease candidate has hit its primary endpoint. But, with the result falling ...
Under normal conditions, cytokines aid in pathogen recognition and elimination while contributing to immune system ...
Zacks Investment Research on MSN
ZBIO tanks despite positive data from rare autoimmune diseases study
Zenas BioPharma ZBIO announced that the phase III INDIGO study, which evaluated its lead pipeline candidate, obexelimab, for ...
Hutchmed is preparing to file for approval of a drug for the rare autoimmune disorder warm antibody autoimmune haemolytic ...
Asal Shirazi, Founder of ASA Foundation, shares insights into what drives inflammatory responses, including the role of ...
What's an Autoimmune Disease? Autoimmune diseases result when your immune system is overactive, causing it to attack and damage your body's own tissues. Normally, your immune system creates proteins ...
The collaboration with Sanofi focuses on developing bispecific antibodies for autoimmune diseases, leveraging predictive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback